The pharmaceutical industry, led by PPMA Chairman Tauqeer Ul Haq, has urged reforms to the Central Research Fund (CRF), proposing that the 1% mandatory contribution be redirected to in-house R&D. This move aims to boost innovation, ensure global regulatory compliance, and reduce bureaucratic inefficiencies.
